Publications by authors named "Roberto Stasi"

Claim this Profile
M
Mycophenolate mofetil therapy for severe immune thrombocytopenia.
Alice Taylor, Lucy Neave, Shalini Solanki, John Paul Westwood, Ilaria Terrinonive, Roberto Stasi

Br J Haematol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A curious case of haemolysis, seizure and acute renal failure associated with pregnancy.
Konstantinos Koutroutsos, Jennifer Jardine, Louise Ross, Aris Papageorghiou, Roberto Stasi

J Nephrol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is B-cell depletion still a good strategy for treating immune thrombocytopenia?
Bertrand Godeau, Roberto Stasi

Presse Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17).
Sergio Amadori, Stefan Suciu, Roberto Stasi, Helmut R Salih, Dominik Selleslag

J Clin Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.
Francesco Rodeghiero, Roberto Stasi, Aristoteles Giagounidis, Jean-François Viallard, Bertrand Godeau

Eur J Haematol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rozrolimupab, a first-in-class recombinant monoclonal antibody product for primary immune thrombocytopaenia.
Sandra Easdale, Roberto Stasi

Expert Opin Biol Ther· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.
Nicola Vianelli, Francesca Palandri, Nicola Polverelli, Roberto Stasi, Joel Joelsson

Haematologica· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to approach thrombocytopenia.
Roberto Stasi

Hematology Am Soc Hematol Educ Program· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.
Francesco Rodeghiero, Marc Michel, Terry Gernsheimer, Marco Ruggeri, Victor Blanchette, Roberto Stasi

Blood· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How I treat thrombocytopenia in pregnancy.
Terry Gernsheimer, Andra H James, Roberto Stasi

Blood· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location.
Giampiero Francica, Alessandra Petrolati, Enrico Di Stasio, Sara Pacella, Roberto Stasi

AJR Am J Roentgenol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refusal of blood transfusion by Jehovah's Witness women: a survey of current management in obstetric and gynaecological practice in the U.K.
Sahana Gupta, Joseph Onwude, Roberto Stasi, Isaac Manyonda

Blood Transfus· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.
Nichola Cooper, Roberto Stasi, Susanna Cunningham-Rundles, Ethel Cesarman, Janice G McFarland

Br J Haematol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care.
Roberto Stasi, Magaral Murali, Marc Michel, Jean-François Viallard, Aristoteles Giagounidis

Int J Hematol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune thrombocytopenia: pathophysiologic and clinical update.
Roberto Stasi

Semin Thromb Hemost· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.
Vivek L Patel, Matthieu Mahévas, Soo Y Lee, Roberto Stasi, Susanna Cunningham-Rundles

Blood· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of ablative margin on local tumor progression and survival in patients with HCC ≤4 cm after laser ablation.
Giampiero Francica, Alesssandra Petrolati, Enrico Di Stasio, Sara Pacella, Roberto Stasi

Acta Radiol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romiplostim for the early management of severe immune thrombocytopenia unresponsive to conventional treatment.
Giuseppe Tagariello, Roberto Sartori, Paolo Radossi, Nilla Maschio, Renzo Risato, Roberto Stasi

Br J Haematol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107).
Sergio Amadori, Roberto Stasi, Alberto M Martelli, Adriano Venditti, Giovanna Meloni

Br J Haematol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ITP, interrupted.
Roberto Stasi

Blood· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiology and therapeutic options in primary immune thrombocytopenia.
Roberto Stasi

Blood Transfus· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ITP: a historical perspective.
Roberto Stasi, Adrian C Newland

Br J Haematol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The stingy bone marrow and the wasteful peripheral blood: a tale of two ITPs.
Roberto Stasi

Blood· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura.
Roberto Stasi

Curr Opin Mol Ther· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired amegakaryocytic thrombocytopenia: potential role of thrombopoietin receptor agonists.
Robert Lown, Elizabeth Rhodes, Jenny Bosworth, Muriel S Shannon, Roberto Stasi

Clin Adv Hematol Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis